90 related articles for article (PubMed ID: 133787)
1. Fluphenazine decanoate in the treatment of chorea: a double-blind study.
Terrence CF
Curr Ther Res Clin Exp; 1976 Aug; 20(2):177-83. PubMed ID: 133787
[No Abstract] [Full Text] [Related]
2. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Cookson JC; Kennedy NM; Gribbon D
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
[TBL] [Abstract][Full Text] [Related]
3. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
5. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
Winter K; Fullerton AG; Hussain K; Tarlo L
Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
[No Abstract] [Full Text] [Related]
6. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Chouinard G; Annable L; Campbell W; Boisvert D; Bradwejn J
Psychopharmacol Bull; 1984; 20(1):108-9. PubMed ID: 6371871
[No Abstract] [Full Text] [Related]
7. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
Leong OK; Wong KE; Tay WK; Gill RC
Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
[TBL] [Abstract][Full Text] [Related]
8. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
Odejide OA; Aderounmu AF
J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
[TBL] [Abstract][Full Text] [Related]
9. [Clinical observations of treatment with Lyorodin-depot (Jenapharm)].
Pirozynski T; Chiriţă V; Cosmovici N; Offenberg C; Chiriac ME; Marinescu V; Cojocaru M; Berlescu M; Mungiu A
Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):501-9. PubMed ID: 2700035
[TBL] [Abstract][Full Text] [Related]
10. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
Rifkin A; Quitkin F; Kane J; Klein DF
Psychopharmacol Bull; 1977 Apr; 13(2):49-50. PubMed ID: 323910
[No Abstract] [Full Text] [Related]
11. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
Ngui PW
Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
[No Abstract] [Full Text] [Related]
12. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
Zhang YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
[No Abstract] [Full Text] [Related]
13. [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients].
La Mura G; Specchio LM; Corfiati L; Porro V; Bertolino A
Acta Neurol (Napoli); 1974; 29(4):446-59. PubMed ID: 4615572
[No Abstract] [Full Text] [Related]
14. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
15. [Flufenazine decanoate in the ambulatory treatment of schizophrenic patients].
Populin M; De Vanna M; Poldrugo F
Minerva Psichiatr; 1981; 22(2):85-92. PubMed ID: 7022095
[No Abstract] [Full Text] [Related]
16. Treatment of patients dependent on tobacco with fluphenazine decanoate.
Drtil J
Act Nerv Super (Praha); 1989 Jun; 31(2):116-7. PubMed ID: 2800941
[No Abstract] [Full Text] [Related]
17. Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
Gaby N; Lefkowitz D; Israel JR
N C Med J; 1982 Sep; 43(9):641-4. PubMed ID: 6958987
[No Abstract] [Full Text] [Related]
18. Clinical experience with fluphenazine decanoate in the treatment of patients with long-standing chronic schizophrenia.
Christodoulidis H; Frangos H
Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):193-8. PubMed ID: 809234
[No Abstract] [Full Text] [Related]
19. The use of fluphenazine decanoate (Modecate)depot therapy in outpatient schizophrenics-a retrospective study.
Tan CT; Ong TC; Chee KT
Singapore Med J; 1981 Aug; 22(4):214-8. PubMed ID: 7323829
[No Abstract] [Full Text] [Related]
20. Is the treatment of tobacco dependence with fluphenazine decanoate a causal treatment?
Drtil J; Balasová G; Jandová E; Duchácková K
Act Nerv Super (Praha); 1990 Dec; 32(4):301-2. PubMed ID: 2082649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
